Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Change lifestyle before giving children weight loss medication, WHO says
In its first global guidelines for child and adolescent obesity, the WHO says diet, exercise, and behavioural changes should be the first port of call.
Read Full Article
Pharma Tech
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
The US FDA has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.
Read Full Article
Pharma Tech
CPHI 2026: Finding the right CDMO partner in an age of consolidation
Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing.
Read Full Article
Pharma Tech
Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed
Experts discuss the latest research released at EASD 2026 and what it could mean for the diabetes community.
Read Full Article
Pharma Tech
10x Genomics and Fred Hutch partner on cancer technologies
10x Genomics has entered into a multi-project research agreement with Fred Hutch for advancing single cell as well as spatial platforms in solid tumours and blood cancers.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Oct 8, 2026, 1:30 PM
PharmaShots Magazine-Oct-2026 Edition
Shots: The post PharmaShots Magazine-Oct-2026 Edition appeared first on PharmaShots.
PharmaShots
Oct 8, 2026, 12:30 PM
Ultragenyx to Sell Rare Pediatric Disease Voucher for $210M
Shots: Ref: Globenewswire |  Image: Ultragenyx  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ultragenyx to Sell Rare Pediatric Disease Voucher for $210M appeared first on PharmaShots.
PharmaShots
Oct 8, 2026, 11:30 AM
Bayer Reports US FDA sNDA Acceptance for Kerendia to Treat Non-Diabetic CKDÂ
Shots: Ref: Businesswire |  Image: Bayer  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Bayer Reports US FDA sNDA Acceptance for Kerendia to Treat Non-Diabetic CKD appeared first on PharmaShots.
PharmaShots
Oct 8, 2026, 10:30 AM
Asieris and Theramex Partner to Expand Cevira Across Europe and Other Markets
Shots: Ref: Businesswire |  Image: Pfizer  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Asieris and Theramex Partner to Expand Cevira Across Europe and Other Markets appeared first on PharmaShots.
Pharma Tech
Oct 8, 2026, 10:08 AM
Change lifestyle before giving children weight loss medication, WHO says
In its first global guidelines for child and adolescent obesity, the WHO says diet, exercise, and behavioural changes should be the first port of call.
Pharma Tech
Oct 8, 2026, 10:05 AM
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
The US FDA has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.
News
Latest industry coverage
Google News
Oct 8, 2026, 8:43 PM
Particle Engineering Takes Center Stage as Pharma Formulation Science Pushes Toward the Clinic - Bioengineer.org
Particle Engineering Takes Center Stage as Pharma Formulation Science Pushes Toward the Clinic  Bioengineer.org
Google News
Oct 8, 2026, 8:40 PM
Maine residents could qualify for compensation in generic drug price-fixing settlements - WMTW
Maine residents could qualify for compensation in generic drug price-fixing settlements  WMTW
Google News
Oct 8, 2026, 8:21 PM
World Spatial FFPE Transcriptomics Assays - Market Analysis, Forecast, Size, Trends and Insights - IndexBox
World Spatial FFPE Transcriptomics Assays - Market Analysis, Forecast, Size, Trends and Insights  IndexBox
Google News
Oct 8, 2026, 8:17 PM
Aptar Expands Pharma Operations in Mumbai, Reinforcing India as a Strategic Growth Market - Aptar
Aptar Expands Pharma Operations in Mumbai, Reinforcing India as a Strategic Growth Market  Aptar
Google News
Oct 8, 2026, 8:10 PM
Harmony Biosciences (HRMY) Heads To European Narcolepsy Days With New Phase 3 Data - Yahoo Finance
Harmony Biosciences (HRMY) Heads To European Narcolepsy Days With New Phase 3 Data  Yahoo Finance
Google News
Oct 8, 2026, 7:53 PM
The billion-dollar question: Where are all the Canadian biotech unicorns? - RBC Thought Leadership -
The billion-dollar question: Where are all the Canadian biotech unicorns?  RBC Thought Leadership -
Google News
Oct 8, 2026, 6:55 PM
New PDUFA deal allots money to rehire FDA reviewers lost to layoffs, trade groups say - Endpoints News
New PDUFA deal allots money to rehire FDA reviewers lost to layoffs, trade groups say  Endpoints News
Google News
Oct 8, 2026, 6:51 PM
Biotech company Obatala Sciences launches first east coast operation in Charleston County - WCIV
Biotech company Obatala Sciences launches first east coast operation in Charleston County  WCIV
Google News
Oct 8, 2026, 6:30 PM
Bio-Techne Opens GMP-Grade Small-Molecule Manufacturing Facility in Bristol, UK - Contract Pharma
Bio-Techne Opens GMP-Grade Small-Molecule Manufacturing Facility in Bristol, UKÂ Â Contract Pharma
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer